That’s Avient. 21,000+ CUSTOMERS >75% ARE CUSTOMIZED SOLUTIONS TO UNIQUE SPECIFICATIONS of sales 6 AVIENT’S VALUE CREATION LEVERS 7 Exposure to high growth end markets Investment in commercial resources and innovation Strong free cash flow generation / capital deployment Clariant Masterbatch synergies COVID recovery Re-Rating: Current share price valuation Avient is poised for near-term and long-term shareholder value creation. We will deliver for our stakeholders through multiple value creation levers—many of which are unique to Avient: o Demand for sustainable solutions, healthcare, and composites, together with Clariant Masterbatch revenue synergies, that will drive 2021 revenue growth of 8% and long-term growth in excess of GDP o Clariant Masterbatch cost synergy capture will result in significant near-term benefit In addition, we remain committed to increasing annual dividends in line with earnings growth and opportunistically buying back shares, all while remaining modestly levered.

Destocking appears to be nearing an end in many end markets; fourth quarter adjusted EPS projected to be 12% higher than prior year. Patterson said, “We are not seeing a recovery in demand as we had initially modeled for the fourth quarter, but we are encouraged that the pace of destocking has slowed and appears to be nearing an end in many end markets including packaging, which is our largest.”

That’s Avient. 21,000+ CUSTOMERS >75% ARE CUSTOMIZED SOLUTIONS TO UNIQUE SPECIFICATIONS of sales 18 AVIENT’S VALUE CREATION LEVERS 19 Exposure to high growth end markets Investment in commercial resources and innovation Strong free cash flow generation / capital deployment Clariant Masterbatch synergies COVID recovery Re-Rating: Current share price valuation Avient is poised for near-term and long-term shareholder value creation. 20 • 8% increase in sales drives 24% increase in adjusted EPS to $2.40 ($2.70 excluding step-up depreciation and amortization) as a result of continued growth in sustainable solutions and synergy capture • Clariant synergy capture ahead of schedule: $35M of savings planned from Clariant Masterbatch acquisition • Adjusted EBITDA of $510M – highest level in company history • Deleveraging ahead of schedule – 2.1x net debt to adjusted EBITDA by the end of 2021 2021 PROJECTIONS PEER COMPARISONS 21 As a specialty formulator, we don’t require significant capital investment, as compared to the base resin raw material suppliers we purchase from. We will deliver for our stakeholders through multiple value creation levers—many of which are unique to Avient: o Demand for sustainable solutions, healthcare, and composites, together with Clariant Masterbatch revenue synergies, that will drive 2021 revenue growth of 8% and long-term growth in excess of GDP o Clariant Masterbatch cost synergy capture will result in significant near-term benefit In addition, we remain committed to increasing annual dividends in line with earnings growth and opportunistically buying back shares, all while remaining modestly levered.

Not all countries have adopted the same GHS requirements in the same way or in the same timeframe; there are still differences that likely will not go away in the near term.

This ability to flow freely in a near-melted state is an important property because it allows TPEs to be molded into any shape you want.

These solutions are well suited for environments where smoke mitigation is of particular concern, such as enclosed spaces and where means of escape is restricted such as hotels, hospitals, skyscrapers, cinemas and theaters, ect.

That’s Avient. 21,000+ CUSTOMERS >75% ARE CUSTOMIZED SOLUTIONS TO UNIQUE SPECIFICATIONS of sales AVIENT’S VALUE CREATION LEVERS 7 Exposure to high growth end markets Investment in commercial resources and innovation Strong free cash flow generation / capital deployment Clariant Masterbatch synergies COVID recovery Re-Rating: Current share price valuation Avient is poised for near-term and long-term shareholder value creation. We will deliver for our stakeholders through multiple value creation levers—many of which are unique to Avient: o Demand for sustainable solutions, healthcare, and composites, together with Clariant Masterbatch revenue synergies, that will drive 2021 revenue growth of 8% and long-term growth in excess of GDP o Clariant Masterbatch cost synergy capture will result in significant near-term benefit In addition, we remain committed to increasing annual dividends in line with earnings growth and opportunistically buying back shares, all while remaining modestly levered.

PolyOne’s safety observation systems and near miss reporting mechanisms also play an important role in ensuring health and safety by providing associates with an opportunity to report unsafe conditions and behaviors. In our databases, we document safety and environmental incidents and near misses at our sites as well as along our transportation routes. Incident and near miss investigations are a critical element of continuous improvement.

Sources Cash from Balance Sheet $465 New Senior Unsecured Notes 650 New Equity 450 Total Sources $1,565 Uses Clariant Masterbatch $1,500 Clariant India Masterbatch 60 Less: Lease Adjustment (113) Net Purchase Price $1,447 Net Cash Acquired 57 Fees, Expenses & OID 61 Total Uses $1,565 ($ Millions) Cash and Cash Equivalents $370 $450M Senior Secured ABL Revolver - Senior Secured Term Loan B due 2026 624 Other Debt 25 Total Senior Secured Debt $649 5.25% Senior Unsecured Notes due 2023 $600 New Senior Unsecured Notes 650 Total Senior Debt $1,899 Net Debt $1,529 New Equity $450 Pro Forma Capitalization (1) PF 12/31/2019 $450 $600 $624 $743 2019 2020 2021 2022 2023 2024 2025 2026 A T T R A C T I V E F I N A N C I N G S T R U C T U R E Attractive Debt Maturity Profile Existing Revolver Existing Senior Notes Existing Term Loan B New Debt Summary Terms on New Debt  $465 million of cash from the balance sheet expected to fund a portion of the purchase price  Bridge financing for remainder fully committed from Citi, Morgan Stanley and Wells Fargo  Permanent financing expected to include a combination of long-term debt and new equity  The timing of the permanent financing is subject to a number of factors, including, but not limited to, market conditions  PolyOne is committed to preserving a strong balance sheet – Target net leverage at close below 3.5x, excluding synergies  Pro forma capital structure positions PolyOne with flexibility to pursue continued growth strategy  New financing expected to have same or better covenant package than existing capital structure  Capital structure would be “covenant lite” Capital Policy  Transaction in line with PolyOne’s disciplined capital allocation policy  Existing PolyOne dividend policy to be maintained  Focus on deleveraging in the near term 2028+ PolyOne Corporation 26 PolyOne Corporation 27 T H E N E W P O L Y O N E : A S P E C I A L T Y G R O W T H C O M P A N Y  Landmark portfolio transformation: > 85% of Adjusted EBITDA from specialty solutions  World-class innovation, technology and service are differentiators  Sustainability initiatives and alignment with megatrends drive above market growth in key end markets and applications:  Capital management is a strength - proven track record of expanding ROIC while increasing invested capital Transaction expected to add $0.85 to pro forma adjusted EPS PolyOne Corporation 28 PolyOne Corporation 29

Explore these eco-conscious materials offering a negative, neutral or near-zero product carbon footprint (Chinese language version) Explore these eco-conscious materials offering a negative, neutral or near-zero product carbon footprint.